Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a.
暂无分享,去创建一个
P. Lampertico | H. Janssen | M. Brunetto | P. Ferenci | B. Hansen | F. Tabak | V. Rijckborst | Y. Çakaloğlu | M. Colombo | V. Messina | L. Regep | C. Iannacone | B. Massetto | A. Lanza